Your browser doesn't support javascript.
loading
Receipt of medications for opioid use disorder among youth engaged in primary care: data from 6 health systems.
Bagley, Sarah M; Chavez, Laura; Braciszewski, Jordan M; Akolsile, Mary; Boudreau, Denise M; Lapham, Gwen; Campbell, Cynthia I; Bart, Gavin; Yarborough, Bobbi Jo H; Samet, Jeffrey H; Saxon, Andrew J; Rossom, Rebecca C; Binswanger, Ingrid A; Murphy, Mark T; Glass, Joseph E; Bradley, Katharine A.
Afiliación
  • Bagley SM; Boston Medical Center, Boston University, Boston, USA. sarah.bagley@bmc.org.
  • Chavez L; Nationwide Children's Hospital, Abigail Wexner Research Institute, Columbus, USA.
  • Braciszewski JM; Center for Health Policy and Health Services Research, Henry Ford Health System, Detroit, USA.
  • Akolsile M; Department of Psychiatry, Henry Ford Health System, Detroit, USA.
  • Boudreau DM; Kaiser Permanente Washington Health Research Institute, Seattle, USA.
  • Lapham G; Kaiser Permanente Washington Health Research Institute, Seattle, USA.
  • Campbell CI; Nationwide Children's Hospital, Abigail Wexner Research Institute, Columbus, USA.
  • Bart G; Division of Research, Kaiser Permanente Northern California, Oakland, USA.
  • Yarborough BJH; University of Minnesota Medical School/Hennepin Healthcare, Minneapolis, USA.
  • Samet JH; Kaiser Permanente Northwest Center for Health Research, Portland, USA.
  • Saxon AJ; Boston Medical Center, Boston University, Boston, USA.
  • Rossom RC; Center of Excellence in Substance Addiction Treatment and Education, VA Puget Sound Health Care System/University of Washington School of Medicine, Seattle, USA.
  • Binswanger IA; Health Partners Institute/University of Minnesota, Minneapolis, USA.
  • Murphy MT; Colorado Permanente Medical Group, Kaiser Permanente Colorado, The University of Colorado School of Medicine and The Kaiser Permanente Bernard J. Tyson School of Medicine, Aurora, USA.
  • Glass JE; MultiCare Institute for Research and Innovation, MultiCare Health System WA, Tacoma, USA.
  • Bradley KA; Kaiser Permanente Washington Health Research Institute, Seattle, USA.
Addict Sci Clin Pract ; 16(1): 46, 2021 07 07.
Article en En | MEDLINE | ID: mdl-34233750
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 / 8_ODS3_consumo_sustancias_psicoactivas Problema de salud: 1_sistemas_informacao_saude / 2_sustancias_psicoativas / 8_opioid_abuse Asunto principal: Buprenorfina / Trastornos Relacionados con Opioides Tipo de estudio: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Humans País/Región como asunto: America do norte Idioma: En Revista: Addict Sci Clin Pract Asunto de la revista: TRANSTORNOS RELACIONADOS COM SUBSTANCIAS Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 / 8_ODS3_consumo_sustancias_psicoactivas Problema de salud: 1_sistemas_informacao_saude / 2_sustancias_psicoativas / 8_opioid_abuse Asunto principal: Buprenorfina / Trastornos Relacionados con Opioides Tipo de estudio: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Humans País/Región como asunto: America do norte Idioma: En Revista: Addict Sci Clin Pract Asunto de la revista: TRANSTORNOS RELACIONADOS COM SUBSTANCIAS Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos